Pfizer's demolition plans in Groton stymie local officials

Now that Pfizer ($PFE) has wrapped up its big round of layoffs in Groton, CT, the company is bringing in the wrecking ball. And its plan to raze Building 118, Pfizer's sprawling 750,000-square-foot research facility on the campus, has made the locals hopping mad, from the governor on down. Report

Suggested Articles

Alexion Pharmaceuticals names its first chief diversity officer as the rare disease specialist looks to cultivate diversity and inclusion.

BMS executives pointed to upcoming Opdivo data releases, as well as strong demand for other drugs in the portfolio, as reasons for optimism.

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back.